CHI Releases Pre-Registrant List for its 5th Integrated R&D Informatics & Knowledge Management Event

Jan. 15, 2013 - PRLog -- As the world of drug discovery gets smaller, and companies become more dependent on collaborations and outsourcing to move forward, the line separating IT from researchers is harder to see. It is crucial for sites to find global enterprise solutions to enable data integration and information sharing within and across internal and external departments.  This conference will highlight strategic infrastructures being put in place to facilitate knowledge sharing and collaborations, including novel approaches to work with data from external and public sources, leverage data from multiple internal sources, establish an effective bioregistry, manage sequencing data, and support complex clinical candidates like ADCs.

125+ Pre-registered delegates (partial list):

Acumenta Corp.
VP, Sales & Marketing

Advanced Chemistry Dev Inc.
Director, Global Strategy & Management

AIST Koto
Team Leader

American Laboratory    
Editor

Appistry Inc.
Consultant

AstraZeneca Pharmaceuticals Inc.
Global Head
Principal Scientist II

Atrium Research & Consulting
CEO

Bayer HealthCare AG
Sr. Expert

Berg Pharma    
President & CTO

Binocular Vision          
Managing Director

Biocartis SA      
CTO
Executive Chairman

BioFortis Inc.
Director, Marketing

Bio-IT World
Editor in Chief

Biotechnology Industry Organization
Director, Diagnostics & Personalized Medicine Policy

Broad Institute
Lead Architect IT & Head

Cancer Commons
Executive Director
Founder and Chairman

Canterbury District Heath Board          
Clinical Director

Catholic Health Initiatives        
National Director, Center of Tranlational Research

Cedars Sinai Medical Center    
Medical Director

Celgene Corp.
Director, Medical Operations

Certara
Director

ChemAxon Ltd
Director
Sr. Application Scientist

CINJ    
Director, Precision Medicine

City of Hope National Medical Center
Director, Research Informatics

CollaborationFinder      
President

Collaborative Drug Discovery Inc.        
CEO & President

College of American Pathologists        
Director, Personalized Healthcare Initiatives

Cycle Computing LLC  
CEO

Dolcera          
Sr. Scientist

Duke University
Project Leader

Eli Lilly & Co.
Computational Medicinal Chemist
Manager, Research Chemistry Systems
Research Advisor

Elsevier          
Scientist

ExxonMobil Research & Engineering Co.
Sr. Research Associate, Computing

Ezose Sciences          
Director, Scientific Affairs

Feinstein Kean Healthcare      
Chairman

Flagship Biosciences LLC        
CEO

Gartner Group
Director, Research

GlaxoSmithKline          
Sr. Scientific Investigator, Computational Biology

H. Lee Moffitt Cancer Center & Research Institute      
President & CEO

Handok Pharmaceuticals
Scientist          

Harvard Medical School          
Research Associate, Biomedical Informatics

Heriot Watt University
Professor, Exercise Biology

IBM TJ Watson Research Center
Post Doctoral Researcher, Functional Genomics & Systems Biology

IDBS    
VP, Translational Medicine

IGNYTA
CSO
Director, Bioinformatics
VP, Corporate Development

Innogenetics NV          
Analytical Method Development Manager

INNOPSYS Inc.
Account Mgr

Institute for Systems Biology  
Associate Professor

IO Informatics Inc.
Director, Business Development

IPSEN Pharma  
Director, Translational Bioinformatics

Janssen Pharmaceuticals Inc.
Manager, Informatics

Johns Hopkins University
Research Associate, Clinical Immunology

Johnson & Johnson Pharmaceutical R&D          
VP Informatics

JSR Corp.
Manager, Diagnostics and Reagents Business

Kyowa Hakko Kirin Co. Ltd.      
Sr. Scientist, Antibody Research Labs

Lab Connections
Sr. Scientist, Bioinformatics

LABVANTAGE Solutions Inc.
Account Manager, Life Sciences Biobanking

LHASA Ltd.
Product Mgr
Project Leader, Software Development

LIMSource        
Editor

Linguamatics  
Sr. Director, North American Sales

MD Anderson Cancer Center
Scientific Applications Specialist

MDxHealth Inc.
Program Mgr

Merck & Co.
Executive Director, Project & Pipeline Management

Merck Research Labs
Director of Cheminformatics

Saurashtra University  
Lab Technician

SomaLogic Inc.
CTO

Stanford University
PostDoc Research Fellow, Genetics
Professor, Genetics

Swiss Institute of Bioinformatics          
Chairman & Co Founder

TeselaGen Biotechnology Inc.
CEO

Thomson Reuters        
Solution Specialist
Solutions Specialist
VP, Disruptive Innovation IP & Science

Ultralight Histology      
Scientist

Uniformed Services
University of The Health Sciences        
Scientist

As part of the Molecular Med TRI-CON 2013, attendees have access to 5 symposia, 18 short courses, and 20 core programs around 5 scientific channels: diagnostics, therapeutics, clinical, informatics, and cancer. The event attracts than 3,000 attendees and provides attendees an opportunity to interact with each other in the shared exhibit/poster hall, plenary keynotes and social functions.

Advance registration discounts are available until January 18, 2013. To learn more and to register, please visit http://www.TriConference.com/Discovery-Informatics

To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, jstroup@healthtech.com.

Writers and editors are encouraged to attend. To request a press pass, contact Lisa Scimemi lscimemi@healthtech.com.

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI) (www.healthtech.com) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI’s Media Group, which includes news websites and e-newsletters including Bio-IT World and eCliniqua. Founded in 1992, CHI strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments.

Contact:
James Prudhomme
Cambridge Healthtech Institute
(781) 972-5400
jprudhomme@healthtech.com